Guidelines

https://www.gov.uk/drug-safety-update


http://www.derbyshiremedicinesmanagement.nhs.uk/medicines-management/clinical-guidelines/patient_group_directions

Patient Group Directions

The tables below include two sets of PGDs; table 1 includes those approved for local use across Derbyshire only and; table 2 includes those jointly approved by Public Health England and NHS England for use across all NHS England North Midlands Practices.

The Resuscitation Council (UK) has directed that a PGD for adrenaline injection is not required for anyone (whether a healthcare professional or not) to administer intramuscular adrenaline for the purpose of saving a life in an emergency. Further information can be found at www.resus.org.uk

Individual Staff PGD Authorisation Form

Table 1: Derbyshire PGDs for use across Derbyshire only

 

PGD Expiry Date
Hepatitis A – Adult N.B. If you are unable to get stock please consider the use of a PSD Oct 2020
Hepatitis A – Child N.B. If you are unable to get stock please consider the use of a PSD Oct 2020
Hepatitis A and Typhoid N.B. If you are unable to get stock please consider the use of a PSD Oct 2020
Levonorgestrel Dec 2021
Typhoid – Children and Adults Oct 2020
Ulipristal Acetate 30mgs June 2021
Vitamin K Oct 2020

 

Table 2: PHE PGDs are available for all NHS England North Midlands Practices

PGD Expiry Date
BCG Vaccine AJV to individuals from birth to 16 years at increased risk of tuberculosis Aug 2020
Diphtheria – Tetanus – Acellular Pertussis – Inactivated Polio Vaccine (dTaP/IPV) to individuals from 3 years 4 months to under 10 years of age Nov 2021
Diptheria – Tetanus – Acellular Pertussis – Inactivated Polio Vaccine (dTaP/IPV) BOOSTERIX (for pregnant women only) Mar 2021
Diptheria – Tetanus – Acellular Pertussis – Inactivated Polio Vaccine HIB and Hep B (DTaP/IPV/Hib/Hep B) Aug 2021
HIB and Men Group C July 2020
HIB and Men Group C – for individuals at increased risk due to an underlying medical condition (from 2 years of age) Oct 2020
HPV Vaccine Aug 2021
Hepatitis B Recombinant DNA (rDNA) Vaccine Apr 2021
Low Dose – Diptheria – Tetanus – Inactivated Polio Vaccine (TdIPV) REVAXIS Oct 2021
Measles, Mumps and Rubella (MMR) Feb 2022
Meningococcal A, C, W 135 & Y conjugate vaccine (Nimenrix or Menveo) July 2021
Meningococcal A, C, W 135 & Y conjugate vaccine – for individuals at increased risk due to an underlying medical condition Feb 2021
Meningococcal Group B Vaccine (Bexsero) Feb 2021
Meningococcal Group B Vaccine (Bexsero) – for individuals at increased risk due to an underlying medical condition Feb 2021
Pneumococcal Polysaccharide Conjugate Vaccine Feb 2022
Pneumococcal Polysaccharide Conjugate Vaccine – for individuals at increased risk due to an underlying medical condition Feb 2022
Pneumococcal Polysaccharide Vaccine (PPV) Aug 2020
Rotavirus June 2021
Shingles (Herpes Zoster) Vaccine (Zostavax) Mar 2021


 


 



https://www.nottsapc.nhs.uk/covid-19/

Medicines FAQs and resources

The medicines optimisation team are logging responses to medicine related queries related to COVID 19.

The FAQs are updated regularly to reflect additional queries and changing advice. To ensure that you are seeing the most up to date information, refresh the page by pressing Ctrl and F5 together.

Care Homes

Respiratory

End of Life / Palliative Care


 

Guidelines

 

Clinical Guidelines

The following guidelines have been approved by the Nottinghamshire Area Prescribing Committee and the relevant secondary care trust(s) Drugs and Therapeutics Committee(s) (D&TCs).

They have been developed in association with the relevant clinicians in primary, secondary and tertiary care (where applicable).

Please click here if you would like the NAPC to consider any clinical guidelines you are developing.

A to Z List of Clinical Guidelines

John McMurray

Glitazones

https://www.bjd-abcd.com/index.php/bjd/article/view/65/141

https://abcd.care/position-papers

https://abcd.care/sites/abcd.care/files/site_uploads/Resources/Position-Papers/SGLT2-inhibitors-ABCD.pdf

SGLT2-inhibitors-ABCD[1]

https://www.dorsetccg.nhs.uk/Downloads/aboutus/medicines-management/COVID-19/SGLT2i%20and%20COVID%2027-4-20.pdf

*** slgts insulin – ketoacidosis jcem2849

****http://www.oxfordshireformulary.nhs.uk/chaptersSubDetails.asp?FormularySectionID=6&SubSectionRef=06.01.02.03&SubSectionID=A100

SGLT2 inhibition and ketoacidosis – should we be concerned?

***https://www.bjd-abcd.com/index.php/bjd/article/view/104/223

https://www.healio.com/news/endocrinology/20190312/inpatient-diabetic-ketoacidosis-more-frequent-with-sglt2-inhibitor-use

https://diabetes.medicinematters.com/en-GB/sglt2-inhibitors/ketoacidosis/recommendations-issued-for-managing-sglt2-inhibitor-associated-d/16464884

https://tam.nhsh.scot/home/formularies-and-the-pink-one/endocrine-system/diabetes/oral-antidiabetic-drugs/sodium-glucose-co-transporter-2-sglt2-inhibitors/

https://www.oxfordhealth.nhs.uk/wp-content/uploads/2017/08/TYpe-2-diabetes-what-to-do-when-you-are-unwell.pdf

https://www.oxfordshireccg.nhs.uk/professional-resources/documents/gp-weekly-bulletin/2020/January/29/primary-care-SGLT2i-alert-january-2020.pdf

See local SGLT2 inhibitor resources available:
 GP Information https://clinox.info/clinical-support/local-pathways-and-guidelines/Clinical%20Guidelines/SGLT2i-warning-primary-care%20final.pdf
 Patient Information Leaflet https://clinox.info/clinical-support/local-pathways-and-guidelines/Clinical%20Guidelines/SGLT2i%20Safety%20Alert%20Resources.pdf
 GP Checklist https://clinox.info/clinical-support/local-pathways-and-guidelines/Clinical%20Guidelines/SGLT2i_Checklist_Final.pdf

https://clinox.info/clinical-support/local-pathways-and-guidelines/Clinical%20Guidelines/SGLT2i-warning-primary-care%20final.pdf

Risk of Diabetic Ketoacidosis in patients with Type 2 Diabetes taking SGLT2
inhibitors
(Dapagliflozin/Forxiga, Canagliflozin/Invokana, Empagliflozin/Jardiance and
Ertugliflozin/Steglatro)
What is the problem?
There have been case reports of Diabetic Ketoacidosis (DKA) in patients taking
SGLT2 inhibitors. These were severe enough to require hospitalisation. These
were not classical DKAs as the majority of these cases occur in patients with
type 2 diabetes and occurred even in the presence of normal or low blood
glucose concentrations, which can delay the diagnosis. These episodes of DKA
were triggered in some cases by stress (e.g. illness and surgery); however in
some cases no trigger was found.

 

Nottinghamshire Joint Formulary




 

Shared Care

Shared Care Protocols outline prescribing and monitoring responsibilities for the specialist and the GP.

Shared Care Protocols (SCPs) are used to allow prescribing to be taken on by a patient’s GP once the patient is stable.

If you are a clinician and want to develop a shared care protocol please click here to contact us.

Below is a list of approved Shared Care Protocols:

Nottinghamshire Joint Formulary

 

 


NICE guidance

Evidence-based recommendations developed by independent committees, including professionals and lay members, and consulted on by stakeholders.

 


 

 

 

Get our COVID-19 updates

COVID-19 rapid guideline: severe asthma

NICE guideline [NG166]Published date: 

  1. Coronavirus (COVID-19)

    We’re supporting the NHS and social care to respond quickly to the challenges of the coronavirus pandemic. We’ve brought together information that may help you.

  2. COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community (NG165)

    The purpose of this guideline is to ensure the best treatment for adults with suspected or confirmed pneumonia in the community during the COVID-19 pandemic and best use of NHS resources. We have withdrawn our guideline on diagnosing and managing pneumonia in adults until further notice. For general advice on managing COVID-19 symptoms, see the NICE COVID-19 rapid guideline on managing symptoms (including at the end of life) in the community .

    TypeCOVID-19 rapid guideline
    Published 
  3.  Pneumonia

    Everything NICE has said on assessing and managing community- and hospital-acquired pneumonia in an interactive flowchart

    TypeNICE Pathway
    Last updated 



https://www.nice.org.uk/guidance/published?type=apg,csg,cg,cov,mpg,ph,sg,sc



 

https://www.resus.org.uk/search?search=covid

  1. Resuscitation Council UK statement on COVID–19 in relation to non-acute hospital settings

    … Resuscitation Council UK statement on COVID–19 in relation to non-acute hospital settings Download … of guidance required for their staff. 1. Purpose 1.1. COVID

  2. COVID-19: FAQs for Healthcare Professionals

    … COVID-19: FAQs for Healthcare Professionals In response to the COVID-19 pandemic, Resuscitation Council UK has produced a … on our guidance for healthcare

  3. Resuscitation Council UK statement on COVID-19 for healthcare workers (HCW) in primary and community healthcare settings

    … Resuscitation Council UK statement on COVID-19 for healthcare workers (HCW) in primary and … and independent sector: click here to view 1. Purpose 1.1  COVID-19

  4. Statements on COVID-19 (Coronavirus): Primary Care Settings

    … Statements on COVID-19 (Coronavirus): Primary Care Settings Statements Resuscitation Council UK statement on COVID–19 in relation to primary care settings (

  5. Statements on COVID-19: In-hospital Settings

    … Statements on COVID-19: In-hospital Settings Statements UPDATED: RCUK … 28 April 2020) Resuscitation Council UK Statement on COVID-19 in relation to CPR and

  6. Statements and resources on COVID-19 (Coronavirus), CPR and Resuscitation

    … Statements and resources on COVID-19 (Coronavirus), CPR and Resuscitation   Resuscitation Council UK is closely monitoring COVID-19’s impact in the UK.   We are

  7. ReSPECT Resources

    … information Top 10 Tips  Information for Care Homes COVID ReSPECT Guidance 23042020.pdf ReSPECT A4 Leaflet (94KB) …

  8. Newsletter

    … up to the newsletter Recent newsletters Newsletter #50 – COVID Resource (April 2020)  Newsletter #49 – Bystander CPR, …

  9. Resuscitation Council UK Statement on COVID-19 in relation to CPR and resuscitation in first aid and community settings

    … Resuscitation Council UK Statement on COVID-19 in relation to CPR and resuscitation in first aid … on increasing experience in the care of patients with COVID

  10. Palliative-Care-Pain-and-Symptom-Control-Guidelines

https://www.resus.org.uk/professional-resources

 

https://patient.info/doctor/six-week-baby-check

  1. NHS Newborn and Infant Physical Examination programme; Public Health England (2013)
  2. Healthy Child Programme: pregnancy and the first five years of life; Dept of Health
  3. Healthy child programme 0 to 19: health visitor and school nurse commissioning; Public Health England (2018)
  4. Postnatal care up to 8 weeks after birth; NICE Clinical Guideline (December 2014, updated February 2015)
  5. National congenital anomaly and rare disease registration service. Congenital anomaly statistics 2015; Public Health England, 2017
  6. Ophthalmic Services for Children; Royal College of Ophthalmologists, 2012
  7. EAU Paediatric Urology Guidelines. Edn. presented at the EAU Annual Congress Copenhagen; European Association of Urology, 2018
  8. NHS Newborn hearing screening programme; Public Health England
  9. Division of ankyloglossia (tongue-tie) for breastfeeding; NICE Interventional Procedure Guidance, December 2005
  10. Sudden Infant Death Syndrome – A guide for professionals; The Lullaby Trust
  11. Oral health promotion: general dental practice; NICE Guidance (December 2015)
  12. Antenatal and postnatal mental health: summary of updated NICE guidance; Antenatal and postnatal mental health: summary of updated NICE guidance. BMJ. 2014 Dec 18349:g7394. doi: 10.1136/bmj.g7394.

 

 



 

 

https://www.gov.uk/drug-safety-update

https://www.gov.uk/government/publications/drug-safety-update-monthly-newsletter

 

  1. MHRA guidance on Coronavirus (COVID-19)
  2. Drug and device alerts
  3. Drug Safety Update
  4. Yellow Card: Report a problem with a medicine or medical device
  5. Blood regulation and safety
  6. Marketing authorisations and licensing guidance
  7. Patient information leaflets and summaries of product characteristics
  8. Public assessment reports
  9. Medical devices regulation and safety
  10. Contact MHRA
  11. All MHRA services and information

Guidance for paediatric services
https://www.rheumatology.org.uk/

https://wd.nottinghamcitycare.nhs.uk/general-practice/protected-learning-time-plt/

 

 

https://www.nottinghamcity.nhs.uk/gp-resources/

 

Practice resources

Infection prevention and control documents (Citycare templates)

Free Online Learning

Nursing Times Learning

Macmillan Resources Hub

Free Open Access Medical Education

Oxford Medical Education

Nurse.com – OnCourse learning for free

Useful links
My pain profile helps you identify the signs that someone is in pain:
https://www.dyingmatters.org/sites/default/files/user/images/pain%20assessment%2
0tool%20Notts%20final%20doc.pdf
The Disability Distress Assessment Tool (DisDAT) is based on the idea that each
person has their own ‘vocabulary’ of distress signs and behaviours:
https://www.wamhinpc.org.uk/sites/default/files/Dis%20DAT_Tool.pdf
Non-Communicating Adults Pain Checklist (NCAPC) is an 18-item checklist that
helps you assess chronic pain in non-communicating adults. https://cpb-use1.
wpmucdn.com/wordpressua.uark.edu/dist/9/300/files/2017/04/Non-
Communicating-Adult-Pain-Checklist.pdf
Wong and Baker’s FACES Pain Rating Scale uses pictures of faces to help people
communicate pain intensity from ‘no hurt’ to ‘hurts worst’:

Instructions for Use


Information on the Mental Capacity Act:

Comments are closed.